表紙
市場調查報告書

乳房切片設備的全球市場:2019年∼2023年

Breast Biopsy Devices Market by Product, End-users, Modality, and Geography - Global Forecast & Analysis 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 913613
出版日期 內容資訊 英文 175 Pages
訂單完成後即時交付
價格
Back to Top
乳房切片設備的全球市場:2019年∼2023年 Breast Biopsy Devices Market by Product, End-users, Modality, and Geography - Global Forecast & Analysis 2019-2023
出版日期: 2019年09月30日內容資訊: 英文 175 Pages
簡介

全球乳房切片設備市場上,乳癌的盛行率的增加,及產品展示及核準的增加等成為成長促進因素,到在預測期間內預計以超過10%的年複合成長率擴大。但,乳房切片的高成本,替代的非侵入性手術的存在,乳房切片伴隨的併發症,及熟練專家不足等要素,可能妨礙在預測期間內乳房切片設備產業的成長。

本報告提供全球乳房切片設備市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各產品

  • 市場區隔:各產品
  • 比較:產品市場規模及預測(2018年∼2023年)
  • 切片穿刺針/系統
  • 切片檢查影像誘導系統
  • 其他
  • 市場機會:各產品

第7章 市場區隔:各種模式

  • 定位X光超音波指南的切片檢查
  • 超音波指南的切片檢查
  • MRI超音波指南的切片檢查

第8章 客戶形勢

第9章 市場區隔:各終端用戶

  • 醫院
  • ASC (門診外科手術中心)
  • 乳癌專門中心及診所
  • 其他

第10章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第11章 決策架構

第12章 成長要素與課題

  • 市場成長要素
  • 市場課題

第13章 市場趨勢

第14章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第15章 供應商分析

  • 交易廠商
  • 供應商分類
  • Market positioning of vendor
  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Co.
  • Carestream Health Inc.
  • Danaher Corp.
  • FUJIFILM Holdings
  • General Electric Co.
  • Hologic Inc.
  • Planmed Oy
  • Scion Medical Technologies LLC
  • Siemens Healthineers AG

第16章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第17章 關於TECHNAVIO

目錄
Product Code: IRTNTR32121

About this market

Technavio's breast biopsy devices market analysis considers sales from biopsy needles and systems, biopsy image-guided systems, and other products. Our analysis report also considers finds the sales of breast biopsy devices in Asia, Europe, North America, and ROW. In 2018, the biopsy needles and systems segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the reduced technical complexities associated with biopsy needles and systems will play a significant role in the biopsy needles and systems segment to maintain its market position. Also, our global breast biopsy devices market report looks at factors such as the growing prevalence of breast cancer cases and an increasing number of products showcasing and approvals. However, high cost of breast biopsy, presence of alternative non-invasive procedures, and complications associated with breast biopsy and lack of trained professionals may hamper the growth of the breast biopsy devices industry over the forecast period.

Overview

Growing prevalence of breast cancer cases

Breast cancer is a deadly health condition and prevalent in women across the world. Even young women have a higher risk of developing breast cancer if they have a genetic propensity for ovarian and breast cancer or if there is a mutation in their BRCAI and BRCA2 gene. This is driving the need to create awareness and treat the patients after a proper analysis. Professionals are gathering a wide range of accumulative data and establishing facilities to encourage patients to undergo screening and diagnosis. This will boost the demand for breast biopsy procedures in various healthcare units. This growing prevalence of breast cancer cases will lead to the expansion of the global breast biopsy devices market at a CAGR of over 10% during the forecast period.

Paradigm shift toward the adoption of breast biopsy robot systems

There is an increase in the demand for technologically advanced breast biopsy devices comprising of robotic platforms, artificial intelligence, and surgical navigation systems. This is due to the growing demand need for minimally invasive procedures and accurate accurate and efficient surgical procedures. Vendors are focusing on improving the healthcare outcomes by developing technological solutions integrated with AI. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global breast biopsy devices market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of several major players, the global breast biopsy devices market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast biopsy devices manufacturers, that include Argon Medical Devices Inc., Becton, Dickinson and Co., Carestream Health Inc., Danaher Corp., FUJIFILM Holdings Corp., General Electric Co., Hologic Inc., Planmed Oy, Scion Medical Technologies LLC, and Siemens Healthineers AG.

Also, the breast biopsy devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming future growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1. Preface
  • 2.2. Preface
  • 2.3. Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Biopsy needles and systems - Market size and forecast 2018-2023
  • Biopsy image-guided systems - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: MARKET SEGMENTATION BY MODALITY

  • Stereotactic X-ray guided breast biopsy
  • Ultrasound-guided breast biopsy
  • MRI-guided breast biopsy

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER

  • Hospitals
  • ASCs
  • Breast cancer specialty centers and clinics
  • Others

PART 10: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario
  • PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendor
  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Co.
  • Carestream Health Inc.
  • Danaher Corp.
  • FUJIFILM Holdings Corp.
  • General Electric Co.
  • Hologic Inc.
  • Planmed Oy
  • Scion Medical Technologies LLC
  • Siemens Healthineers AG

PART 16: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 17: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Product overview
  • Exhibit 02: Global medical devices market
  • Exhibit 03: Segments of global medical devices market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Product - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Biopsy needles and systems - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Biopsy needles and systems - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Biopsy image-guided systems - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Biopsy image-guided systems - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 25: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 26: Market opportunity by product
  • Exhibit 27: Global breast biopsy devices market by modality (based on biopsy image-guided systems) in 2018
  • Exhibit 28: Customer landscape
  • Exhibit 29: Global breast biopsy devices market by end-user 2018
  • Exhibit 30: Market share by geography 2018-2023 (%)
  • Exhibit 31: Geographic comparison
  • Exhibit 32: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: Estimated cancer incidence in European countries 2018
  • Exhibit 36: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 38: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 41: Key leading countries
  • Exhibit 42: Reimbursement by Medicare for breast biopsy in the US
  • Exhibit 43: Market opportunity
  • Exhibit 44: Estimated incidence cases of cancer in European countries (2018)
  • Exhibit 45: Impact of drivers and challenges
  • Exhibit 46: Business strategies and their market impact analysis
  • Exhibit 47: Vendor landscape
  • Exhibit 48: Landscape disruption
  • Exhibit 49: Vendors covered
  • Exhibit 50: Vendor classification
  • Exhibit 51: Market positioning of vendors
  • Exhibit 52: Argon Medical Devices Inc. - Vendor overview
  • Exhibit 53: Argon Medical Devices Inc. - Business segments
  • Exhibit 54: Argon Medical Devices Inc. - Organizational developments
  • Exhibit 55: Argon Medical Devices Inc. - Key offerings
  • Exhibit 56: Argon Medical Devices Inc. - Key customers
  • Exhibit 57: Becton, Dickinson and Co. - Vendor overview
  • Exhibit 58: Becton, Dickinson and Co. - Product segments
  • Exhibit 59: Becton, Dickinson and Co. - Organizational developments
  • Exhibit 60: Becton, Dickinson and Co. - Geographic focus
  • Exhibit 61: Becton, Dickinson and Co. - Segment focus
  • Exhibit 62: Becton, Dickinson and Co. - Key offerings
  • Exhibit 63: Becton, Dickinson and Co. - Key customers
  • Exhibit 64: Carestream Health Inc. - Vendor overview
  • Exhibit 65: Carestream Health Inc. - Business segments
  • Exhibit 66: Carestream Health Inc. - Organizational developments
  • Exhibit 67: Carestream Health Inc. - Key offerings
  • Exhibit 68: Carestream Health Inc. - Key customers
  • Exhibit 69: Danaher Corp. - Vendor overview
  • Exhibit 70: Danaher Corp. - Business segments
  • Exhibit 71: Danaher Corp. - Organizational developments
  • Exhibit 72: Danaher Corp. - Geographic focus
  • Exhibit 73: Danaher Corp. - Segment focus
  • Exhibit 74: Danaher Corp. - Key offerings
  • Exhibit 75: Danaher Corp. - Key customers
  • Exhibit 76: FUJIFILM Holdings Corp. - Vendor overview
  • Exhibit 77: FUJIFILM Holdings Corp. - Business segments
  • Exhibit 78: FUJIFILM Holdings Corp. - Organizational developments
  • Exhibit 79: FUJIFILM Holdings Corp. - Geographic focus
  • Exhibit 80: FUJIFILM Holdings Corp. - Segment focus
  • Exhibit 81: FUJIFILM Holdings Corp. - Key offerings
  • Exhibit 82: FUJIFILM Holdings Corp. - Key customers
  • Exhibit 83: General Electric Co. - Vendor overview
  • Exhibit 84: General Electric Co. - Business segments
  • Exhibit 85: General Electric Co. - Organizational developments
  • Exhibit 86: General Electric Co. - Geographic focus
  • Exhibit 87: General Electric Co. - Segment focus
  • Exhibit 88: General Electric Co. - Key offerings
  • Exhibit 89: General Electric Co. - Key customers
  • Exhibit 90: Hologic Inc. - Vendor overview
  • Exhibit 91: Hologic Inc. - Business segments
  • Exhibit 92: Hologic Inc. - Organizational developments
  • Exhibit 93: Hologic Inc. - Geographic focus
  • Exhibit 94: Hologic Inc. - Segment focus
  • Exhibit 95: Hologic Inc. - Key offerings
  • Exhibit 96: Hologic Inc. - Key customers
  • Exhibit 97: Planmed Oy - Vendor overview
  • Exhibit 98: Planmed Oy - Product segments
  • Exhibit 99: Planmed Oy - Organizational developments
  • Exhibit 100: Planmed Oy - Key offerings
  • Exhibit 101: Planmed Oy - Key customers
  • Exhibit 102: Scion Medical Technologies LLC - Vendor overview
  • Exhibit 103: Scion Medical Technologies LLC - Product segments
  • Exhibit 104: Scion Medical Technologies LLC - Key offerings
  • Exhibit 105: Scion Medical Technologies LLC - Key customers
  • Exhibit 106: Siemens Healthineers AG - Vendor overview
  • Exhibit 107: Siemens Healthineers AG - Business segments
  • Exhibit 108: Siemens Healthineers AG - Organizational developments
  • Exhibit 109: Siemens Healthineers AG - Geographic focus
  • Exhibit 110: Siemens Healthineers AG - Segment focus
  • Exhibit 111: Siemens Healthineers AG - Key offerings
  • Exhibit 112: Siemens Healthineers AG - Key customers
  • Exhibit 113: Validation techniques employed for market sizing
  • Exhibit 114: Definition of market positioning of vendors
Back to Top